Amgen

PROLIA

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Amgen

Prolia HCPCS:

J0897

HCPCS Code Descriptor:

Injection, denosumab, 1 mg

Category:

J Code

Prolia NDCs:

55513-0730-01, 55513-0710-01

Primary Type:

Osteoporosis

Generic/Specialty Status:

Single-Source

Package Type:

Multiple

Route of Administration:

Subcutaneous

Prolia CPT Codes:

Potential CPT administration codes for Prolia can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Prolia:

PROLIA is an Osteoporosis drug manufactured by Amgen and administered via the Subcutaneous route of administration. The J Code: J0897 is aligned to the drug PROLIA.

Prolia, also known as Denosumab, is used to treat osteoporosis and prevent bone fractures. Prolia works by blocking a molecule in the body called RANKL. RANKL is responsible for bone metabolism. By blocking this molecule, Prolia build and strengthen the bones, preventing breaks and fractures and helping to relieve the symptoms of osteoporosis. Prolia is administered as an injection.

ACCESS PRICING AND MORE BY REGISTERING

J0897 Added Date:

January 1, 2012

J0897 Effective Date:

January 1, 2012

J0897 Termination Date:

HCPCS Active

Prolia billing and coding information can be found through Amgen at the link below:
Prolia patient assistance information can be found through Amgen Assist at the URL: https://www.amgenassist.com/copay
PROLIA prescribing information can be found at the link below:
Information regarding PROLIA’s side effects can be found at MedlinePlus